nuvaring vaginaalravivahend
organon n.v. - etonogestreel+etünüülöstradiool - vaginaalravivahend - 120mcg+15mcg 24h 3tk; 120mcg+15mcg 24h 1tk
pediaven nn2 infusioonilahus
fresenius kabi polska sp. z o.o. - kombinatsioonid - infusioonilahus - 250ml 10tk
pediaven g20 infusioonilahus
fresenius kabi polska sp. z o.o. - kombinatsioonid - infusioonilahus - 1000ml 4tk
hemosol b0 hemodialüüsi-/hemofiltratsioonilahus
baxter holding b.v. - kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+piimhape+naatriumvesinikkarbonaat+naatriumkloriid - hemodialüüsi-/hemofiltratsioonilahus - 5,145g+2,033g+5,4g+3,09g+6,45g 1l 5000ml 2tk
pediaven g25 infusioonilahus
fresenius kabi polska sp. z o.o. - kombinatsioonid - infusioonilahus - 1000ml 4tk
raboral v-rg suukaudne suspensioon
boehringer ingelheim animal health france - marutaudi elusviirusvaktsiin - suukaudne suspensioon - 1annus 1annus 800tk; 1annus 1annus 200tk
pediaven nn1 infusioonilahus
fresenius kabi polska sp. z o.o. - kombinatsioonid - infusioonilahus - 250ml 10tk
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - mitu müeloomit - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - immunosupressandid - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinuuria, paroksüsmaalne - immunosupressandid - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.